BAUSCH HEALTH AMERICAS, INC.
- Country
- ๐บ๐ธUnited States
- Ownership
- Subsidiary
- Employees
- 3.1K
- Market Cap
- -
- Website
- http://www.bauschhealth.com
The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmoiditis
- First Posted Date
- 2011-05-06
- Last Posted Date
- 2019-08-14
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 114
- Registration Number
- NCT01349673
- Locations
- ๐บ๐ธ
Gastroenterology Consultants, PA, Houston, Texas, United States
A Study of a New Drug Treatment for Acne
- Conditions
- Interventions
- First Posted Date
- 2011-03-31
- Last Posted Date
- 2019-10-16
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 431
- Registration Number
- NCT01326780
- Locations
- ๐บ๐ธ
Thomas J. Stephens & Associates, Inc., Colorado Springs, Colorado, United States
๐บ๐ธHilltop Research, Miamiville, Ohio, United States
๐บ๐ธWake Research Associates, Raleigh, North Carolina, United States
A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products
- Conditions
- Interventions
- First Posted Date
- 2011-03-14
- Last Posted Date
- 2012-02-15
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT01313728
- Locations
- ๐บ๐ธ
Skin Study Center, Broomall, Pennsylvania, United States
A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants With Chronic, Non-Malignant Pain
- Conditions
- Interventions
- First Posted Date
- 2010-08-23
- Last Posted Date
- 2019-09-06
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 804
- Registration Number
- NCT01186770
- Locations
- ๐บ๐ธ
PRA International, Raleigh, North Carolina, United States
๐บ๐ธPRA, Intl., Raleigh, North Carolina, United States
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
- Conditions
- Interventions
- First Posted Date
- 2010-08-09
- Last Posted Date
- 2019-11-21
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 148
- Registration Number
- NCT01177410
A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's Disease
- Conditions
- Interventions
- First Posted Date
- 2010-06-24
- Last Posted Date
- 2012-06-22
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT01149811
- Locations
- ๐บ๐ธ
University of South Florida, Tampa, Florida, United States
๐บ๐ธCNS Network, Inc., Torrance, California, United States
๐บ๐ธAdvanced Neurodiagnostic Center, Metairie, Louisiana, United States
A Study of Safety and Tolerability of Fipamezole in Adult Subjects With Parkinson's Disease Who Are Receiving Levodopa
- First Posted Date
- 2010-06-10
- Last Posted Date
- 2011-08-31
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01140841
- Locations
- ๐บ๐ธ
CNS Network, Inc., Torrance, California, United States
๐บ๐ธClinical Research Integrity Worldwide LLC, Willingboro, New Jersey, United States
๐บ๐ธQuest Research Institute, Bingham Farms, Michigan, United States
A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome
- First Posted Date
- 2010-05-28
- Last Posted Date
- 2019-11-29
- Lead Sponsor
- Bausch Health Americas, Inc.
- Registration Number
- NCT01133353
Metyrosine (Demserยฎ) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome
- Conditions
- Interventions
- First Posted Date
- 2010-05-21
- Last Posted Date
- 2019-11-22
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT01127503
- Locations
- ๐บ๐ธ
VCFS International Center, Syracuse, New York, United States
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
- First Posted Date
- 2010-04-09
- Last Posted Date
- 2019-07-30
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 181
- Registration Number
- NCT01101100
- Locations
- ๐ซ๐ท
Research Site, Toulouse Cedex 9, France